NCT01481844View on ClinicalTrials.gov

Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection

PHASE3CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Optimization of Second Line Treatment Protocol for H Pylori Eradication

Interventions

DRUG

Lansoprazole , Tab Amoxycillin , Tab Clarithromycin ,Tab Tinidazole

use of Sequential therapy as second line treatment for eradication H pylori currently Sequential therapy is indicated as first line treatment for H pylori eradication

DRUG

Lansoprazole, Bismuth Subsalicylate, Metronidazole, Tetracycline

this combination is standard of care as H pylori second line treatment

Trial Locations (1)

Unknown

Soroca UMC, Beersheba

All Listed Sponsors

lead

Soroka University Medical Center

OTHER

NCT01481844 - Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection | Biotech Hunter | Biotech Hunter